首页 | 本学科首页   官方微博 | 高级检索  
检索        

联合使用干细胞因子、FLT3配基与白介素2,7,15体外扩增人脐血来源CIK/NK细胞
引用本文:黎阳,黄绍良,吴燕峰,魏菁,包蓉,周敦华.联合使用干细胞因子、FLT3配基与白介素2,7,15体外扩增人脐血来源CIK/NK细胞[J].中国实验血液学杂志,2004,12(3):350-354.
作者姓名:黎阳  黄绍良  吴燕峰  魏菁  包蓉  周敦华
作者单位:1. 中山大学附属第二医院儿科,广州,510120
2. 中山大学干细胞研究中心,广州,510120
3. 中山大学医学研究中心,广州,510120
基金项目:2 0 0 3年广东省自然科学基金资助项目,编号 0 3 170 7
摘    要:通过干细胞因子 (SCF)、FLT3配基 (FL)联合白介素 (IL) 2 ,7,15等的不同组合体系体外扩增人脐血来源的CIK NK细胞 (CB CIK NK) ,探讨不同培养方式对CB CIK NK细胞诱导、扩增产率的影响。按诱导扩增体系的不同分 3组 :A组 (SCF IL2 IL7 IL15 ) ,B组 (SCF FL IL2 IL7 IL15 )和C组 (IL2 IL7 IL15 ,对照组 ) ,培养 2 1天 ,检测CD3 CD5 6 CIK细胞、CD3- CD5 6 NK细胞比例和扩增倍数。结果表明 :经 2 1天培养 ,A ,B及C组CIK细胞比例分别为 (19.84± 2 .93) %、(2 6 .2 0± 4 .0 5 ) %及 (2 4 .0 3± 4 .99) % ;而NK细胞的比例A、B及C组比例分别为 (4 9.6 0± 1.4 0 ) %、(5 1.16± 6 .4 5 ) %及 (30 .85± 8.12 ) %。含SCF FL的B组扩增效率最高 ,其中CIK细胞的扩增倍数由对照组 (C组 )的 (5 75 81± 2 2 1.72 )倍增加至 (796 .0 9± 2 78.4 7)倍 (最高为 1313倍 ) ;NK细胞由对照组 (C组 )的 (30 .39± 14 .4 7)倍增加至 (6 5 .85± 30 .83)倍 (最高为 12 1.0 6倍 )。结论 :通过合适的细胞因子组合可以同时扩增CB来源的CIK NK细胞 ;联合诱导、扩增CB CIK NK细胞以采用含SCF FL IL2 IL7 IL15的培养体系为佳。

关 键 词:CIK/NK细胞  脐血  干细胞因子  FLT3配基  白介素2  白介素7  白介素15
文章编号:1009-2137(2004)03-0350-05
修稿时间:2004年2月9日

Expansion of CIK/NK Cells from Cord Blood by Using Different Combinations of Stem Cell Factor,FLT3 Ligand and Interleukin 2,7,15 in vitro
LI Yang,HUANG Shao-Liang,WU Yan-Feng,WEI Jing,BAO Rong,ZHOU Dun-Hua.Expansion of CIK/NK Cells from Cord Blood by Using Different Combinations of Stem Cell Factor,FLT3 Ligand and Interleukin 2,7,15 in vitro[J].Journal of Experimental Hematology,2004,12(3):350-354.
Authors:LI Yang  HUANG Shao-Liang  WU Yan-Feng  WEI Jing  BAO Rong  ZHOU Dun-Hua
Institution:Department of Pediatrics, The Second Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Abstract:To explore the efficacy of the different combinations of stem cell factor (SCF), FLT3 ligand (FL) and interleukin (IL) 2, 7, 15 on the induction and expansion of cord blood (CB) derived CIK/ NK cells in vitro, according to the different combinations of cytokines, combinations of cytokines were divided into 3 groups: group A (SCF + IL2 + IL7 + IL15), group B (SCF + FL + IL2 + IL7 + IL15) and group C (IL2 + IL7 + IL15 as control group). At 21 days of culture, the proportion and the expansion rate of CD3(+)CD56(+) CIK cells and CD3(-)CD56(+) NK cells were measured. The results showed that at 21 days in culture, the percentages of CD3(+)CD56(+) CIK cells derived from CB-MNC in group A, B and C were (19.84 +/- 2.93)%, (26.20 +/- 4.05)%, (24.03 +/- 4.99%) and that of NK cells were (49.60 +/- 1.40)%, (51.16 +/- 6.45)% and (30.85 +/- 8.12)%, respectively. The proliferation of CD3(+)CD56(+) CIK cells and CD3(-)CD56(+) NK cells was the most effective in group B (SCF + FL + IL2 + IL7 + IL15). Expansion multiple of CIK cell number increased from 575.81 +/- 221.72 (control) to 796.09 +/- 278.47 with peak value of 1 313, and that of NK cells increased from 30.39 +/- 14.47 (control) to 65.85 +/- 30.83 with peak value of 121.06. In conclusion, a proper cytokines (SCF + FL + IL2 + IL7 + IL15) culture system can effectively induce and expand CB CD3(+)CD56(+) CIK cells and CD3(-)CD56(+) NK cells simultaneously.
Keywords:CIK/NK cell  cord blood  stem cell factor  FLT3 ligand  IL-2  IL-7  IL-15
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号